We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3993:HKEXCMOC Group Limited Class H Analysis

Data as of 2026-06-13 - not real-time

¥2,625.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

PKSHA Technology is trading well below its DCF-derived fair value of ¥4,846, with the market price around ¥2,625, implying an upside of roughly 37%. The stock sits under all three moving averages (20‑day, 50‑day, 200‑day) and the 200‑day SMA sits near ¥3,344, underscoring a bearish technical backdrop. Momentum indicators are mixed: the RSI at 39 hints at potential oversold conditions, yet the MACD histogram remains negative, confirming bearish momentum. Fundamentally, the company posted an impressive 89% revenue growth year‑over‑year and maintains a solid gross margin of about 49% and operating margin near 19%. The balance sheet shows a moderate debt‑to‑equity ratio of 21% and ample cash reserves exceeding ¥15.8 bn, supporting financial flexibility. Volatility is high at roughly 70% over the past 30 days, and historical drawdowns have reached ‑41%, suggesting price swings can be sharp.
Given the substantial valuation gap and strong growth fundamentals, the stock presents a compelling long‑run thesis, but short‑term traders should respect the current bearish technical signals and tight support around ¥2,586. The absence of a dividend eliminates income considerations, placing the emphasis squarely on capital appreciation. While the tech‑infrastructure sector carries inherent cyclical and regulatory uncertainties, PKSHA’s diversified AI‑driven product suite across retail, automotive, finance, and healthcare provides a buffer against sector‑specific headwinds. Overall, the combination of undervaluation, robust earnings outlook, and solid cash position favours a buy stance for investors with a medium to long horizon, while short‑term positioning calls for caution.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below key moving averages
  • Negative MACD histogram
  • Support level near current price

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation upside
  • Strong revenue growth and margins
  • Robust cash position vs modest debt

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Diversified AI product portfolio
  • Undervalued relative to DCF fair value
  • Sustainable earnings expansion potential

Key Metrics & Analysis

Financial Health

Revenue Growth89.10%
Profit Margin7.95%
P/E Ratio33.3
ROE7.16%
ROA4.75%
Debt/Equity21.13
P/B Ratio2.3
Op. Cash Flow¥5.6B
Free Cash Flow¥3.9B
Industry P/E36.8

Technical Analysis

TrendBearish
RSI39.0
Support¥2,586.00
Resistance¥3,310.00
MA 20¥2,847.10
MA 50¥2,994.58
MA 200¥3,344.34
MACDBearish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair Value¥4,846.17
Target Price¥3,600.00
Upside/Downside37.14%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.94
Volatility69.54%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.